Cardiac Metabolism in Sepsis

dc.contributor.authorKawaguchi, Satoshi
dc.contributor.authorOkada, Motoi
dc.contributor.departmentAnatomy, Cell Biology and Physiology, School of Medicineen_US
dc.date.accessioned2023-04-10T17:04:35Z
dc.date.available2023-04-10T17:04:35Z
dc.date.issued2021-12-06
dc.description.abstractThe mechanism of sepsis-induced cardiac dysfunction is believed to be different from that of myocardial ischemia. In sepsis, chemical mediators, such as endotoxins, cytokines, and nitric oxide, cause metabolic abnormalities, mitochondrial dysfunction, and downregulation of β-adrenergic receptors. These factors inhibit the production of ATP, essential for myocardial energy metabolism, resulting in cardiac dysfunction. This review focuses on the metabolic changes in sepsis, particularly in the heart. In addition to managing inflammation, interventions focusing on metabolism may be a new therapeutic strategy for cardiac dysfunction due to sepsis.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationKawaguchi S, Okada M. Cardiac Metabolism in Sepsis. Metabolites. 2021;11(12):846. Published 2021 Dec 6. doi:10.3390/metabo11120846en_US
dc.identifier.urihttps://hdl.handle.net/1805/32320
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/metabo11120846en_US
dc.relation.journalMetabolitesen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectMetabolic switchen_US
dc.subjectSepsisen_US
dc.subjectβ-adrenergic receptoren_US
dc.titleCardiac Metabolism in Sepsisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
metabolites-11-00846.pdf
Size:
993.74 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: